Evolution of Voice Quality in Type 1-2 Transoral CO


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
07 2022
Historique:
revised: 11 10 2021
received: 26 08 2021
accepted: 13 10 2021
pubmed: 28 10 2021
medline: 18 6 2022
entrez: 27 10 2021
Statut: ppublish

Résumé

To compare the 12-month evolution of voice quality outcomes in patients who benefited from types 1-2 transoral CO Prospective uncontrolled study. Sixty patients with cT1 VFSCC were consecutively recruited from a single medical center. Thirty patients benefited from type 1 TLC, while type 2 TCL was performed in 30 patients. The following voice quality outcomes were evaluated at baseline, 3-, 6-, and 12-month post-TLC: voice handicap index (VHI), GRBAS, speech rate, maximum phonation time (MPT), and acoustic parameters. Voice quality evolution was compared between type 1 and type 2 TLC. Fifty-seven patients completed the evaluations. Type 1 TLC patients reported significant improvements of VHI, grade of dysphonia, and breathiness at 3-, 6-, and 12-month post-TLC. Speech rate and jitter values improved 6- and 12-month post-TLC. A few voice quality outcomes reported 3- or 6-month post-TLC improvements in type 2 TLC group, while VHI, grade of dysphonia improved at 6- and 12-month post-TLC. MPT significantly decreased at 6- and 12-month post-TLC, while there were no acoustic measurement changes in type 2 TLC. The effect of TLC on voice quality may depend on the type of TLC. Type 1 TLC was associated with faster voice quality improvements compared with type 2 TLC. VHI and dysphonia grade were identified as the most relevant tool of voice changes irrespective to the TLC type. 3 Laryngoscope, 132:1421-1426, 2022.

Identifiants

pubmed: 34704611
doi: 10.1002/lary.29924
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1421-1426

Informations de copyright

© 2021 The American Laryngological, Rhinological and Otological Society, Inc.

Références

Hartl DM, Ferlito A, Brasnu DF, et al. Evidence-based review of treatment options for patients with glottic cancer. Head Neck 2011;33:1638-1648.
Eksteen EC, Rieger J, Nesbitt M, Seikaly H. Comparison of voice characteristics following three different methods of treatment for laryngeal cancer. J Otolaryngol 2003;32:250-253.
Nomura T, Ishikawa J, Ohki M, Ohata A, Araki R, Kikuchi S. Multifactorial analysis of local control and survival in patients with early glottic cancer. Laryngoscope 2020;130:1701-1706. https://doi.org/10.1002/lary.28240.
Remacle M, Eckel HE, Antonelli A, et al. Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol 2000;257:227-231.
Remacle M, Van Hauerbeke C, Eckel H, et al. Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol 2007;264:499-504.
Hillel AT, Johns MM 3rd, Hapner ER, Shah M, Wise JC, Klein AM. Voice outcomes from subligamentous cordectomy for early glottic cancer. Ann Otol Rhinol Laryngol 2013;122:190-196. https://doi.org/10.1177/000348941312200308.
Mau T, Palaparthi A, Riede T, Titze IR. Effect of resection depth of early glottic cancer on vocal outcome: an optimized finite element simulation. Laryngoscope 2015;125:1892-1899. https://doi.org/10.1002/lary.25267.
Woisard V, Bodin S, Puech M. [The Voice Handicap Index: impact of the translation in French on the validation]. Rev Laryngol Otol Rhinol (Bord) 2004;125:307-312.
Hirano M. Clinical Examination of Voice. New York: Springer-Verlag; 1981.
Roh JL, Kim DH, Kim SY, Park CI. Quality of life and voice in patients after laser cordectomy for Tis and T1 glottic carcinomas. Head Neck 2007;29:1010-1016. https://doi.org/10.1002/hed.20625.
Ledda GP, Grover N, Pundir V, Masala E, Puxeddu R. Functional outcomes after CO2 laser treatment of early glottic carcinoma. Laryngoscope 2006;116:1007-1011. https://doi.org/10.1097/01.MLG.0000217557.45491.BD.
Staníková L, Zeleník K, Formánek M, et al. Evolution of voice after transoral laser cordectomy for precancerous lesions and early glottic cancer. Eur Arch Otorhinolaryngol 2021;278:2899-2906. https://doi.org/10.1007/s00405-021-06751-3.
Hamzany Y, Crevier-Buchman L, Lechien JR, Bachar G, Brasnu D, Hans S. Multidimensional voice quality evaluation after transoral CO2 laser cordectomy: a prospective study. Ear Nose Throat J 2021;100(1_suppl):27S-32S. https://doi.org/10.1177/0145561320906328.
Keilmann A, Napiontek U, Engel C, Nakarat T, Schneider A, Mann W. Long-term functional outcome after unilateral cordectomy. ORL J Otorhinolaryngol Relat Spec 2011;73:38-46.
Lachowska M, Osuch-Wójcikiewicz E, Bruzgielewicz A. Voice evaluation following endoscopic laser CO(2) cordectomy and conventional cordectomy. Arch Med Sci 2011;7:143-153. https://doi.org/10.5114/aoms.2011.20621.
Lee HS, Kim JS, Kim SW, et al. Voice outcome according to surgical extent of transoral laser microsurgery for T1 glottic carcinoma. Laryngoscope 2016;126:2051-2056. https://doi.org/10.1002/lary.25789.
Chu PY, Hsu YB, Lee TL, Fu S, Wang LM, Kao YC. Longitudinal analysis of voice quality in patients with early glottic cancer after transoral laser microsurgery. Head Neck 2012;34:1294-1298.
Galletti B, Freni F, Cammaroto G, Catalano N, Gangemi G, Galletti F. Vocal outcome after CO2 laser cordectomy performed on patients affected by early glottic carcinoma. J Voice 2012;26:801-805. https://doi.org/10.1016/j.jvoice.2012.01.003.
Lechien JR, Huet K, Finck C, et al. Are the acoustic measurements reliable in the assessment of voice quality? A methodological prospective study. J Voice 2021;35:203-215. https://doi.org/10.1016/j.jvoice.2019.08.022.
Lechien JR, Huet K, Finck C, et al. Clinical and acoustical voice quality evolutions throughout empirical treatment for laryngopharyngeal reflux disease according to gender: a preliminary study. Folia Phoniatr Logop 2019;72:257-266. https://doi.org/10.1159/000500085.
Casimir GJ, Mulier S, Hanssens L, Zylberberg K, Duchateau J. Gender differences in inflammatory markers in children. Shock 2010;33:258-262. https://doi.org/10.1097/SHK.0b013e3181b2b36b.

Auteurs

Jerome R Lechien (JR)

Department of Otolaryngology, Elsan Hospital, Paris, France.
Department of Otorhinolaryngology-Head and Neck Surgery, CHU de Bruxelles, CHU Saint-Pierre, School of Medicine, Brussels, Belgium.
Department of Otorhinolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, Paris Saclay University, Paris, France.

Lise Crevier-Buchman (L)

Department of Otorhinolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, Paris Saclay University, Paris, France.
Phonetics and Phonology Lab, CNRS UMR7018, University of Sorbonne-Nouvelle, Paris, France.

Marta P Circiu (MP)

Department of Otorhinolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, Paris Saclay University, Paris, France.

Quentin Lisan (Q)

Department of Otorhinolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, Paris Saclay University, Paris, France.

Stephane Hans (S)

Department of Otorhinolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, Paris Saclay University, Paris, France.
Phonetics and Phonology Lab, CNRS UMR7018, University of Sorbonne-Nouvelle, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH